Artemis Therapeutics Inc.
ATMS · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | – | $109 | $55 |
| Short-Term Investments | $0 | – | $0 | $0 |
| Receivables | $8 | – | $35 | $41 |
| Inventory | $104 | – | $35 | $47 |
| Other Curr. Assets | $15 | – | $0 | $0 |
| Total Curr. Assets | $128 | – | $179 | $143 |
| Property Plant & Equip (Net) | $40 | – | $78 | $87 |
| Goodwill | $0 | – | -$1 | $0 |
| Intangibles | $32 | – | $35 | $35 |
| Long-Term Investments | $0 | – | $0 | $0 |
| Tax Assets | $0 | – | $0 | $0 |
| Other NC Assets | -$128 | – | $0 | $0 |
| Total NC Assets | -$56 | – | $112 | $122 |
| Other Assets | $0 | – | $0 | $0 |
| Total Assets | $72 | – | $291 | $265 |
| Liabilities | – | – | – | – |
| Payables | $664 | – | $637 | $571 |
| Short-Term Debt | $0 | – | $255 | $105 |
| Tax Payable | $0 | – | $0 | $0 |
| Deferred Revenue | $0 | – | $0 | $0 |
| Other Curr. Liab. | $575 | – | $286 | $328 |
| Total Curr. Liab. | $1,239 | – | $1,178 | $1,004 |
| LT Debt | $318 | – | $242 | $251 |
| Deferred Rev, NC | $0 | – | $0 | $0 |
| Deferred Tax Liab, NC | $0 | – | $0 | $0 |
| Other NC Liab. | $34 | – | $35 | $36 |
| Total NC Liab. | $352 | – | $277 | $287 |
| Other Liabilities | $0 | – | $0 | $0 |
| Cap. Leases | $0 | – | $0 | $0 |
| Total Liabilities | $1,591 | – | $1,455 | $1,291 |
| Equity | – | – | – | – |
| Pref Stock | $0 | – | $0 | $0 |
| Common Stock | $1,120 | – | $1,120 | $1,120 |
| Retained Earnings | -$3,000 | – | -$2,614 | -$2,365 |
| AOCI | $0 | – | $44 | $37 |
| Other Equity | $489 | – | $286 | $182 |
| Total Equity | -$1,391 | – | -$1,164 | -$1,026 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | – | $0 | $0 |
| Total Liab. & Tot. Equity | $200 | – | $291 | $265 |
| Net Debt | $317 | $0 | $388 | $301 |